Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| (12 intermediate revisions by 2 users not shown) | |||
| Line 15: | Line 15: | ||
===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles=== | ===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles=== | ||
| + | |||
| + | * [[Media:QIBA_DWIProfile_Consensus_Dec2019_Final.pdf|Diffusion-Weighted Magnetic Resonance Imaging (DWI) 2019-12-20]] | ||
* [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]] | * [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]] | ||
| Line 34: | Line 36: | ||
'''Please submit comments using the '''[http://tinyurl.com/QIBA-Public-Comment-Form '''online form''']''' | '''Please submit comments using the '''[http://tinyurl.com/QIBA-Public-Comment-Form '''online form''']''' | ||
| − | *[[Media:QIBA_SPECT_99mTC_Profile_10.21.19.pdf|SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21]] (<font color=green>'''Public Comment Open''': November 1, 2019 - February 3, 2020 | + | *[[Media:QIBA_SPECT_99mTC_Profile_10.21.19.pdf|SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21]] (<font color=green>'''Public Comment Open''': November 1, 2019 - February 3, 2020<font>) |
*[[Media:QIBA_US_SWS_Profile_10.21.19.pdf|QIBA US Measurement of Shear Wave Speed for Estimation of Liver Fibrosis Profile 2019-10-21]] ('''closed''' on December 18, 2019) | *[[Media:QIBA_US_SWS_Profile_10.21.19.pdf|QIBA US Measurement of Shear Wave Speed for Estimation of Liver Fibrosis Profile 2019-10-21]] ('''closed''' on December 18, 2019) | ||
| Line 49: | Line 51: | ||
| − | '''[[Comment Resolutions]]''' are posted for '''Past Public Comments''' and '''Past Technical Confirmations''' . | + | '''[[Comment Resolutions]]''' <font color=black>are posted for '''Past Public Comments''' and '''Past Technical Confirmations'''.<font> |
| + | |||
==Format for Citing Profiles== | ==Format for Citing Profiles== | ||
| Line 59: | Line 62: | ||
: QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles | : QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles | ||
| + | |||
==Statements of Endorsement== | ==Statements of Endorsement== | ||
Revision as of 17:29, 14 January 2020
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Profiles may be of use at any Stage.
Stage 3: Technically Confirmed Profiles
- Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
- Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
Please submit comments using the online form
- SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21 (Public Comment Open: November 1, 2019 - February 3, 2020)
- QIBA US Measurement of Shear Wave Speed for Estimation of Liver Fibrosis Profile 2019-10-21 (closed on December 18, 2019)
- Appendix E: QIBA US SWS Checklists for Implementation of the SWS Profile, 2019-10-21 (closed on December 18, 2019)
- QIBA CT Lung Density Profile 2019-09-03 (Contains Conformance Checklist, Appendix B) (closed on October 16, 2019)
- QIBA CT Lung Density Protocols-Appendix D, 2019-06-26 (closed on October 16, 2019)
- Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05 (closed on April 5th, 2019)
- Atherosclerosis Biomarkers by (C)CTA - 2019 Imaging Profile 2019-02-26 (closed on June 3rd, 2019)
Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.
Format for Citing Profiles
Cite QIBA Profile documents as:
- Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL
Example:
- QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)